US research says marijuana extract helps improve rare childhood epilepsy

Researchers recently published two results at the annual meeting of the American Society of epilepsy in Philadelphia, us Studies have shown that cannabis bisphenol (CBD, a substance in marijuana that is not psychoactive) can help treat severe or rare childhood epilepsy Dr Olin devinsky, a neuroscientist at New York University's langney medical center, conducted a three-month study on the treatment of CBD He studied 261 children and young adults with an average age of 11.8 years, most of whom were diagnosed with LGS and Dravet's syndrome According to the research report, the seizure rate of all subjects decreased by 45.1% after using cannabis bisphenol, among which the seizure rate of patients with DS syndrome decreased by 62.7% 47% of the patients had a 50% reduction in attack rate, and 9% of the patients and 13% of the patients with DS had no attack after treatment Since then, researchers at the University of California, San Francisco, have selected 25 epileptics for a one-year CBD treatment study The results showed that the attack rate of 10 patients decreased by at least 50%, and one of them still had no attack until now 12 patients were terminated due to ineffective treatment, and another one had an increased attack rate Doctors concluded that it was related to CBD treatment, so they stopped taking related drugs According to the study, although cannabis bisphenol (CBD) can not play a good role in the treatment of all epilepsy patients, but for most patients, its improvement effect is still significant "We are happy to share these gratifying data with you, not only because they confirm the safety and effectiveness of the research we shared earlier, but most importantly, they can bring hope to children suffering from epilepsy and their families." Original title: US research claims that hemp extract can help improve rare childhood epilepsy